Table of Contents Author Guidelines Submit a Manuscript
Journal of Obesity
Volume 2016 (2016), Article ID 4390254, 8 pages
http://dx.doi.org/10.1155/2016/4390254
Review Article

Bile Acids, FXR, and Metabolic Effects of Bariatric Surgery

1Temple University School of Medicine, Philadelphia, PA 19140, USA
2Penn State College of Medicine, Hershey, PA 17033, USA
3Geisinger Clinic, Danville, PA 17822, USA

Received 29 October 2015; Accepted 31 January 2016

Academic Editor: Francesco Saverio Papadia

Copyright © 2016 Olivier F. Noel et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. Sturm and A. Hattori, “Morbid obesity rates continue to rise rapidly in the United States,” International Journal of Obesity, vol. 37, no. 6, pp. 889–891, 2013. View at Publisher · View at Google Scholar · View at Scopus
  2. D. Hofsø, T. Jenssen, H. Hager, J. Røislien, and J. Hjelmesæth, “Fasting plasma glucose in the screening for type 2 diabetes in morbidly obese subjects,” Obesity Surgery, vol. 20, no. 3, pp. 302–307, 2010. View at Publisher · View at Google Scholar · View at Scopus
  3. J. Chmelar, K.-J. Chung, and T. Chavakis, “The role of innate immune cells in obese adipose tissue inflammation and development of insulin resistance,” Thrombosis and Haemostasis, vol. 109, no. 3, pp. 399–406, 2013. View at Publisher · View at Google Scholar · View at Scopus
  4. A. W. Ferrante Jr., “Obesity-induced inflammation: a metabolic dialogue in the language of inflammation,” Journal of Internal Medicine, vol. 262, no. 4, pp. 408–414, 2007. View at Publisher · View at Google Scholar · View at Scopus
  5. S. Schenk, M. Saberi, and J. M. Olefsky, “Insulin sensitivity: modulation by nutrients and inflammation,” The Journal of Clinical Investigation, vol. 118, no. 9, pp. 2992–3002, 2008. View at Publisher · View at Google Scholar · View at Scopus
  6. S. P. Weisberg, D. McCann, M. Desai, M. Rosenbaum, R. L. Leibel, and A. W. Ferrante Jr., “Obesity is associated with macrophage accumulation in adipose tissue,” The Journal of Clinical Investigation, vol. 112, no. 12, pp. 1796–1808, 2003. View at Publisher · View at Google Scholar · View at Scopus
  7. C. N. Lumeng, S. M. Deyoung, and A. R. Saltiel, “Macrophages block insulin action in adipocytes by altering expression of signaling and glucose transport proteins,” American Journal of Physiology—Endocrinology and Metabolism, vol. 292, no. 1, pp. E166–E174, 2007. View at Publisher · View at Google Scholar · View at Scopus
  8. H. Xu, G. T. Barnes, Q. Yang et al., “Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance,” The Journal of Clinical Investigation, vol. 112, no. 12, pp. 1821–1830, 2003. View at Publisher · View at Google Scholar · View at Scopus
  9. J. Westerink and F. L. J. Visseren, “Pharmacological and non-pharmacological interventions to influence adipose tissue function,” Cardiovascular Diabetology, vol. 10, article 13, 2011. View at Publisher · View at Google Scholar · View at Scopus
  10. K. L. Butner, S. M. Nickols-Richardson, S. F. Clark, W. K. Ramp, and W. G. Herbert, “A review of weight loss following Roux-en-Y gastric bypass vs restrictive bariatric surgery: impact on adiponectin and insulin,” Obesity Surgery, vol. 20, no. 5, pp. 559–568, 2010. View at Publisher · View at Google Scholar · View at Scopus
  11. H. Buchwald, R. Estok, K. Fahrbach et al., “Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis,” The American Journal of Medicine, vol. 122, no. 3, pp. 248.e5–256.e5, 2009. View at Publisher · View at Google Scholar · View at Scopus
  12. J. B. Dixon, D. K. Murphy, J. E. Segel, and E. A. Finkelstein, “Impact of laparoscopic adjustable gastric banding on type 2 diabetes,” Obesity Reviews, vol. 13, no. 1, pp. 57–67, 2012. View at Publisher · View at Google Scholar · View at Scopus
  13. C. V. Ferchak and L. F. Meneghini, “Obesity, bariatric surgery and type 2 diabetes—a systematic review,” Diabetes/Metabolism Research and Reviews, vol. 20, no. 6, pp. 438–445, 2004. View at Publisher · View at Google Scholar · View at Scopus
  14. H. M. Heneghan, S. Nissen, and P. R. Schauer, “Gastrointestinal surgery for obesity and diabetes: weight loss and control of hyperglycemia,” Current Atherosclerosis Reports, vol. 14, no. 6, pp. 579–587, 2012. View at Publisher · View at Google Scholar · View at Scopus
  15. J. P. Thaler and D. E. Cummings, “Minireview: hormonal and metabolic mechanisms of diabetes remission after gastrointestinal surgery,” Endocrinology, vol. 150, no. 6, pp. 2518–2525, 2009. View at Publisher · View at Google Scholar · View at Scopus
  16. A. D. Miras and C. W. le Roux, “Can medical therapy mimic the clinical efficacy or physiological effects of bariatric surgery?” International Journal of Obesity, vol. 38, no. 3, pp. 325–333, 2014. View at Publisher · View at Google Scholar · View at Scopus
  17. G. Mingrone, S. Panunzi, A. De Gaetano et al., “Bariatric surgery versus conventional medical therapy for type 2 diabetes,” The New England Journal of Medicine, vol. 366, no. 17, pp. 1577–1585, 2012. View at Publisher · View at Google Scholar · View at Scopus
  18. R. E. Allen, T. D. Hughes, J. L. Ng et al., “Mechanisms behind the immediate effects of Roux-en-Y gastric bypass surgery on type 2 diabetes,” Theoretical Biology and Medical Modelling, vol. 10, no. 1, article 45, 2013. View at Publisher · View at Google Scholar · View at Scopus
  19. H. Ashrafian, M. Bueter, K. Ahmed et al., “Metabolic surgery: an evolution through bariatric animal models,” Obesity Reviews, vol. 11, no. 12, pp. 907–920, 2010. View at Publisher · View at Google Scholar · View at Scopus
  20. K. T. Nguyen and J. Korner, “The sum of many parts: potential mechanisms for improvement in glucose homeostasis after bariatric surgery,” Current Diabetes Reports, vol. 14, article 481, 2014. View at Publisher · View at Google Scholar · View at Scopus
  21. S. Madsbad, C. Dirksen, and J. J. Holst, “Mechanisms of changes in glucose metabolism and bodyweight after bariatric surgery,” The Lancet Diabetes and Endocrinology, vol. 2, no. 2, pp. 152–164, 2014. View at Publisher · View at Google Scholar · View at Scopus
  22. F. A. McAlister, J. Man, L. Bistritz, H. Amad, and P. Tandon, “Diabetes and coronary artery bypass surgery: an examination of perioperative glycemic control and outcomes,” Diabetes Care, vol. 26, no. 5, pp. 1518–1524, 2003. View at Publisher · View at Google Scholar · View at Scopus
  23. G. Fruhbeck and R. Nogueiras, “GLP-1: the oracle for gastric bypass?” Diabetes, vol. 63, no. 2, pp. 399–401, 2014. View at Publisher · View at Google Scholar · View at Scopus
  24. J. Schirra and B. Göke, “GLP-1—a candidate humoral mediator for glucose control after Roux-en-Y gastric bypass,” Diabetes, vol. 63, no. 2, pp. 387–389, 2014. View at Publisher · View at Google Scholar · View at Scopus
  25. M. Mokadem, J. F. Zechner, R. F. Margolskee, D. J. Drucker, and V. Aguirre, “Effects of Roux-en-Y gastric bypass on energy and glucose homeostasis are preserved in two mouse models of functional glucagon-like peptide-1 deficiency,” Molecular Metabolism, vol. 3, no. 2, pp. 191–201, 2014. View at Publisher · View at Google Scholar · View at Scopus
  26. J. Ye, Z. Hao, M. B. Mumphrey et al., “GLP-1 receptor signaling is not required for reduced body weight after RYGB in rodents,” The American Journal of Physiology—Regulatory Integrative and Comparative Physiology, vol. 306, no. 5, pp. R352–R362, 2014. View at Publisher · View at Google Scholar · View at Scopus
  27. B. J. Sandler, R. Rumbaut, C. P. Swain et al., “Human experience with an endoluminal, endoscopic, gastrojejunal bypass sleeve,” Surgical Endoscopy, vol. 25, no. 9, pp. 3028–3033, 2011. View at Publisher · View at Google Scholar · View at Scopus
  28. K. K. Ryan, V. Tremaroli, C. Clemmensen et al., “FXR is a molecular target for the effects of vertical sleeve gastrectomy,” Nature, vol. 509, no. 7499, pp. 183–188, 2014. View at Publisher · View at Google Scholar · View at Scopus
  29. P. O. Ganrot, K. Gydell, and H. Ekelund, “Serum concentration of alpha-2-macroglobulin, haptoglobin and alpha-1-antitrypsin in diabetes mellitus,” Acta Endocrinologica, vol. 55, no. 3, pp. 537–544, 1967. View at Google Scholar · View at Scopus
  30. F. G. Schaap, M. Trauner, and P. L. M. Jansen, “Bile acid receptors as targets for drug development,” Nature Reviews Gastroenterology and Hepatology, vol. 11, no. 1, pp. 55–67, 2014. View at Publisher · View at Google Scholar · View at Scopus
  31. R. Kohli, D. Bradley, K. D. Setchell, J. C. Eagon, N. Abumrad, and S. Klein, “Weight loss induced by Roux-en-Y gastric bypass but not laparoscopic adjustable gastric banding increases circulating bile acids,” Journal of Clinical Endocrinology and Metabolism, vol. 98, no. 4, pp. E708–E712, 2013. View at Publisher · View at Google Scholar · View at Scopus
  32. G. S. Gerhard, A. M. Styer, G. C. Wood et al., “A role for fibroblast growth factor 19 and bile acids in diabetes remission after Roux-en-Y gastric bypass,” Diabetes Care, vol. 36, no. 7, pp. 1859–1864, 2013. View at Publisher · View at Google Scholar · View at Scopus
  33. A. Myronovych, M. Kirby, K. K. Ryan et al., “Vertical sleeve gastrectomy reduces hepatic steatosis while increasing serum bile acids in a weight-loss-independent manner,” Obesity, vol. 22, no. 2, pp. 390–400, 2014. View at Publisher · View at Google Scholar · View at Scopus
  34. M.-E. Patti, S. M. Houten, A. C. Bianco et al., “Serum bile acids are higher in humans with prior gastric bypass: potential contribution to improved glucose and lipid metabolism,” Obesity, vol. 17, no. 9, pp. 1671–1677, 2009. View at Publisher · View at Google Scholar · View at Scopus
  35. P. L. M. Jansen, J. van Werven, E. Aarts et al., “Alterations of hormonally active fibroblast growth factors after Roux-en-Y gastric bypass surgery,” Digestive Diseases, vol. 29, no. 1, pp. 48–51, 2011. View at Publisher · View at Google Scholar · View at Scopus
  36. S. M. Houten, M. Watanabe, and J. Auwerx, “Endocrine functions of bile acids,” The EMBO Journal, vol. 25, no. 7, pp. 1419–1425, 2006. View at Publisher · View at Google Scholar · View at Scopus
  37. J. Prawitt, S. Caron, and B. Staels, “Bile acid metabolism and the pathogenesis of type 2 diabetes,” Current Diabetes Reports, vol. 11, no. 3, pp. 160–166, 2011. View at Publisher · View at Google Scholar · View at Scopus
  38. M. O. Hoeke, J. Heegsma, M. Hoekstra, H. Moshage, and K. N. Faber, “Human FXR regulates SHP expression through direct binding to an LRH-1 binding site, independent of an IR-1 and LRH-1,” PLoS ONE, vol. 9, no. 2, Article ID e88011, 2014. View at Publisher · View at Google Scholar · View at Scopus
  39. F. Kuipers, V. W. Bloks, and A. K. Groen, “Beyond intestinal soap-bile acids in metabolic control,” Nature Reviews Endocrinology, vol. 10, no. 8, pp. 488–498, 2014. View at Publisher · View at Google Scholar · View at Scopus
  40. A. Fisette, P. Poursharifi, K. Oikonomopoulou, M. N. Munkonda, M. Lapointe, and K. Cianflone, “Paradoxical glucose-sensitizing yet proinflammatory effects of acute ASP administration in mice,” Mediators of Inflammation, vol. 2013, Article ID 713284, 9 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  41. R. Germinario, A. D. Sniderman, S. Manuel, S. P. Lefebvre, A. Baldo, and K. Cianflone, “Coordinate regulation of triacylglycerol synthesis and glucose transport by acylation-stimulating protein,” Metabolism, vol. 42, no. 5, pp. 574–580, 1993. View at Publisher · View at Google Scholar · View at Scopus
  42. B. Cariou, K. van Harmelen, D. Duran-Sandoval et al., “The farnesoid X receptor modulates adiposity and peripheral insulin sensitivity in mice,” The Journal of Biological Chemistry, vol. 281, no. 16, pp. 11039–11049, 2006. View at Publisher · View at Google Scholar · View at Scopus
  43. E. Hertle, M. M. J. van Greevenbroek, and C. D. A. Stehouwer, “Complement C3: an emerging risk factor in cardiometabolic disease,” Diabetologia, vol. 55, no. 4, pp. 881–884, 2012. View at Publisher · View at Google Scholar · View at Scopus
  44. G. S. Hotamisligil, “Inflammation and metabolic disorders,” Nature, vol. 444, no. 7121, pp. 860–867, 2006. View at Publisher · View at Google Scholar · View at Scopus
  45. O. A. Hamad, J. Bäck, P. H. Nilsson, B. Nilsson, and K. N. Ekdahl, “Platelets, complement, and contact activation: partners in inflammation and thrombosis,” Advances in Experimental Medicine and Biology, vol. 946, pp. 185–205, 2012. View at Publisher · View at Google Scholar · View at Scopus
  46. D. Ricklin, G. Hajishengallis, K. Yang, and J. D. Lambris, “Complement: a key system for immune surveillance and homeostasis,” Nature Immunology, vol. 11, no. 9, pp. 785–797, 2010. View at Publisher · View at Google Scholar · View at Scopus
  47. J. G. P. Sissons, R. J. West, J. Fallows et al., “The complement abnormalities of lipodystrophy,” The New England Journal of Medicine, vol. 294, no. 9, pp. 461–465, 1976. View at Publisher · View at Google Scholar · View at Scopus
  48. M. Pattrick, J. Luckett, L. Yue, and C. Stover, “Dual role of complement in adipose tissue,” Molecular Immunology, vol. 46, no. 5, pp. 755–760, 2009. View at Publisher · View at Google Scholar · View at Scopus
  49. A. Hernández-Mijares, C. Bañuls, L. Bellod et al., “Effect of weight loss on C3 and C4 components of complement in obese patients,” European Journal of Clinical Investigation, vol. 42, no. 5, pp. 503–509, 2012. View at Publisher · View at Google Scholar · View at Scopus
  50. A. Onat, G. Can, R. Rezvani, and K. Cianflone, “Complement C3 and cleavage products in cardiometabolic risk,” Clinica Chimica Acta, vol. 412, no. 13-14, pp. 1171–1179, 2011. View at Publisher · View at Google Scholar · View at Scopus
  51. T. Fujita, “Extra-immunological role of complement activation in diabetic nephropathy,” OA Nephrology, vol. 1, no. 2, article 19, 2013. View at Publisher · View at Google Scholar
  52. D. Kalant, S. A. Cain, M. Maslowska, A. D. Sniderman, K. Cianflone, and P. N. Monk, “The chemoattractant receptor-like protein C5L2 binds the C3a des-Arg77/acylation-stimulating protein,” The Journal of Biological Chemistry, vol. 278, pp. 11123–11129, 2003. View at Google Scholar
  53. M. Maslowska, A. D. Sniderman, R. Germinario, and K. Cianflone, “ASP stimulates glucose transport in cultured human adipocytes,” International Journal of Obesity, vol. 21, no. 4, pp. 261–266, 1997. View at Publisher · View at Google Scholar · View at Scopus
  54. Y. Tao, K. Cianflone, A. D. Sniderman, S. P. Colby-Germinario, and R. J. Germinario, “Acylation-stimulating protein (ASP) regulates glucose transport in the rat L6 muscle cell line,” Biochimica et Biophysica Acta, vol. 1344, no. 3, pp. 221–229, 1997. View at Publisher · View at Google Scholar · View at Scopus
  55. D. Gauvreau, A. Gupta, A. Fisette, F.-Q. Tom, and K. Cianflone, “Deficiency of C5L2 increases macrophage infiltration and alters adipose tissue function in mice,” PLoS ONE, vol. 8, no. 4, Article ID e60795, 2013. View at Publisher · View at Google Scholar · View at Scopus
  56. A. Fisette, M. N. Munkonda, K. Oikonomopoulou, S. Paglialunga, J. D. Lambris, and K. Cianflone, “C5L2 receptor disruption enhances the development of diet-induced insulin resistance in mice,” Immunobiology, vol. 218, no. 1, pp. 127–133, 2013. View at Publisher · View at Google Scholar · View at Scopus
  57. J. Li, P. C. Pircher, I. G. Schulman, and S. K. Westin, “Regulation of complement C3 expression by the bile acid receptor FXR,” The Journal of Biological Chemistry, vol. 280, no. 9, pp. 7427–7434, 2005. View at Publisher · View at Google Scholar · View at Scopus
  58. K. Daily, V. R. Patel, P. Rigor, X. Xie, and P. Baldi, “MotifMap: integrative genome-wide maps of regulatory motif sites for model species,” BMC Bioinformatics, vol. 12, article 495, 2011. View at Publisher · View at Google Scholar · View at Scopus
  59. G. Xie, Z. Peng, and J.-P. Raufman, “Src-mediated aryl hydrocarbon and epidermal growth factor receptor cross talk stimulates colon cancer cell proliferation,” The American Journal of Physiology—Gastrointestinal and Liver Physiology, vol. 302, no. 9, pp. G1006–G1015, 2012. View at Publisher · View at Google Scholar · View at Scopus
  60. S. S. Andrali, M. L. Smapley, N. L. Vanderford, and S. Özcan, “Glucose regulation of insulin gene expression in pancreatic β-cells,” Biochemical Journal, vol. 415, no. 1, pp. 1–10, 2008. View at Publisher · View at Google Scholar · View at Scopus
  61. Y. Xu, M. Ma, G. C. Ippolito, H. W. Schroeder Jr., M. C. Carroll, and J. E. Volanakis, “Complement activation in factor D-deficient mice,” Proceedings of the National Academy of Sciences of the United States of America, vol. 98, no. 25, pp. 14577–14582, 2001. View at Publisher · View at Google Scholar · View at Scopus
  62. J. C. Lo, S. Ljubicic, B. Leibiger et al., “Adipsin is an adipokine that improves β cell function in diabetes,” Cell, vol. 158, no. 1, pp. 41–53, 2014. View at Publisher · View at Google Scholar · View at Scopus
  63. C. D. Still, G. C. Wood, X. Chu et al., “High allelic burden of four obesity SNPs is associated with poorer weight loss outcomes following gastric bypass surgery,” Obesity, vol. 19, no. 8, pp. 1676–1683, 2011. View at Publisher · View at Google Scholar · View at Scopus
  64. B. S. Moore, U. L. Mirshahi, E. A. Yost et al., “Long-term weight-loss in gastric bypass patients carrying melanocortin 4 receptor variants,” PLoS ONE, vol. 9, no. 4, Article ID e93629, 2014. View at Publisher · View at Google Scholar · View at Scopus
  65. U. L. Mirshahi, C. D. Still, K. K. Masker, G. S. Gerhard, D. J. Carey, and T. Mirshahi, “The MC4R(I251L) allele is associated with better metabolic status and more weight loss after gastric bypass surgery,” Journal of Clinical Endocrinology and Metabolism, vol. 96, no. 12, pp. E2088–E2096, 2011. View at Publisher · View at Google Scholar · View at Scopus
  66. E. S. Rinella, C. Still, Y. Shao et al., “Genome-wide association of single-nucleotide polymorphisms with weight loss outcomes after Roux-en-Y gastric bypass surgery,” The Journal of Clinical Endocrinology & Metabolism, vol. 98, no. 6, pp. E1131–E1136, 2013. View at Publisher · View at Google Scholar · View at Scopus
  67. I. J. Hatoum, D. M. Greenawalt, C. Cotsapas, M. J. Daly, M. L. Reitman, and L. M. Kaplan, “Weight loss after gastric bypass is associated with a variant at 15q26.1,” The American Journal of Human Genetics, vol. 92, no. 5, pp. 827–834, 2013. View at Publisher · View at Google Scholar · View at Scopus
  68. A. E. Locke, B. Kahali, S. I. Berndt et al., “Genetic studies of body mass index yield new insights for obesity biology,” Nature, vol. 518, no. 7538, pp. 197–206, 2015. View at Publisher · View at Google Scholar
  69. D. Shungin, T. W. Winkler, D. C. Croteau-Chonka et al., “New genetic loci link adipose and insulin biology to body fat distribution,” Nature, vol. 518, no. 7538, pp. 187–196, 2015. View at Publisher · View at Google Scholar
  70. A. A. van der Klaauw and I. S. Farooqi, “The hunger genes: pathways to obesity,” Cell, vol. 161, no. 1, pp. 119–132, 2015. View at Publisher · View at Google Scholar
  71. X. Xie, P. Rigor, and P. Baldi, “MotifMap: a human genome-wide map of candidate regulatory motif sites,” Bioinformatics, vol. 25, no. 2, pp. 167–174, 2009. View at Publisher · View at Google Scholar · View at Scopus
  72. P. F. Duckworth, Z. Reno Vlahcevic, E. J. Studer et al., “Effect of hydrophobie bile acids on 3-hydroxy-3-methylglutaryl-coenzyme A reductase activity and mRNA levels in the rat,” The Journal of Biological Chemistry, vol. 266, no. 15, pp. 9413–9418, 1991. View at Google Scholar · View at Scopus
  73. G. Vivacqua, A. Renzi, G. Carpino, A. Franchitto, and E. Gaudio, “Expression of brain derivated neurotrophic factor and of its receptors: TrKB and p75NT in normal and bile duct ligated rat liver,” Italian Journal of Anatomy and Embryology, vol. 119, no. 2, pp. 111–129, 2014. View at Publisher · View at Google Scholar · View at Scopus
  74. M. Verlaet, A. Adamantidis, B. Coumans et al., “Human immune cells express ppMCH mRNA and functional MCHR1 receptor,” FEBS Letters, vol. 527, no. 1–3, pp. 205–210, 2002. View at Publisher · View at Google Scholar · View at Scopus
  75. J. Krishnan, C. Danzer, T. Simka et al., “Dietary obesity-associated Hif1alpha activation in adipocytes restricts fatty acid oxidation and energy expenditure via suppression of the Sirt2-NAD+ system,” Genes & Development, vol. 26, pp. 259–270, 2012. View at Google Scholar
  76. A. B. Crujeiras, D. Parra, E. Goyenechea, and J. A. Martinez, “Sirtuin gene expression in human mononuclear cells is modulated by caloric restriction,” European Journal of Clinical Investigation, vol. 38, no. 9, pp. 672–678, 2008. View at Publisher · View at Google Scholar · View at Scopus
  77. Y.-T. Huang, J. Z. J. Maccani, N. L. Hawley, R. R. Wing, K. T. Kelsey, and J. M. McCaffery, “Epigenetic patterns in successful weight loss maintainers: a pilot study,” International Journal of Obesity, vol. 39, pp. 865–868, 2015. View at Publisher · View at Google Scholar · View at Scopus
  78. H. Rosas-Vargas, J. D. Martínez-Ezquerro, and T. Bienvenu, “Brain-derived neurotrophic factor, food intake regulation, and obesity,” Archives of Medical Research, vol. 42, no. 6, pp. 482–494, 2011. View at Publisher · View at Google Scholar · View at Scopus
  79. L. A. Lange, C. J. Willer, and S. S. Rich, “Recent developments in genome and exome-wide analyses of plasma lipids,” Current Opinion in Lipidology, vol. 26, no. 2, pp. 96–102, 2015. View at Publisher · View at Google Scholar
  80. A. Parihar, G. C. Wood, X. Chu et al., “Extension of GWAS results for lipid-related phenotypes to extreme obesity using Electronic Health Record (EHR) data and the Metabochip,” Frontiers in Genetics, vol. 5, article 222, 2014. View at Publisher · View at Google Scholar · View at Scopus
  81. G. Xu, L.-X. Pan, H. Li et al., “Dietary cholesterol stimulates CYP7A1 in rats because farnesoid X receptor is not activated,” The American Journal of Physiology—Gastrointestinal and Liver Physiology, vol. 286, no. 5, pp. G730–G735, 2004. View at Publisher · View at Google Scholar · View at Scopus
  82. S. Lim and R. H. Eckel, “Pharmacological treatment and therapeutic perspectives of metabolic syndrome,” Reviews in Endocrine and Metabolic Disorders, vol. 15, no. 4, pp. 329–341, 2014. View at Publisher · View at Google Scholar · View at Scopus